Suggestions

Du même auteur

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT ‐0701 MAPS phase 3 trial

Archive ouverte | Maille, Elodie | CCSD

CERVOXY. International audience. The Hippo pathway effector YAP is dysregulated in malignant pleural mesothelioma (MPM). YAP’s target genes include the secreted growth factor amphiregulin (AREG), which is overexpres...

Cytosolic amphiregulin accumulation in malignant pleural mesothelioma cells predicts better survival of patient from the IFCT-GFPC-0701 MAPS Phase 3 trial

Archive ouverte | Lainé, Baptiste | CCSD

CERVOXY COLL. National audience

L’expression cytosolique tumorale d’amphireguline prédit la meilleure survie des patients atteints de mésothéliome pleural malin : analyses chez 288 patients de la cohorte Bio-MAPS.

Archive ouverte | Lainé, Baptiste | CCSD

CERVOXY. National audience

Chargement des enrichissements...